These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6491814)

  • 1. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord).
    Vande Berg JS; Gelberman RH; Rudolph R; Johnson D; Sicurello P
    J Orthop Res; 1984; 2(3):247-56. PubMed ID: 6491814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myofibroblast in Dupuytren's contracture.
    Rudolph R; Vande Berg J
    Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular actin as a marker for myofibroblasts in vitro.
    Foo IT; Naylor IL; Timmons MJ; Trejdosiewicz LK
    Lab Invest; 1992 Dec; 67(6):727-33. PubMed ID: 1460863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of myofibroblasts in the pathogenesis of Dupuytren's contracture.
    Salamon A; Hámori J
    Acta Morphol Acad Sci Hung; 1980; 28(1-2):71-82. PubMed ID: 7192480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
    Ulrich D; Ulrich F; Piatkowski A; Pallua N
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural relationship of skin to nodule and cord in Dupuytren's contracture.
    VandeBerg JS; Rudolph R; Gelberman R; Woodward MR
    Plast Reconstr Surg; 1982 May; 69(5):835-44. PubMed ID: 7071229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of myofibroblasts in the pathogenesis of Dupuytren's contracture].
    Salamon A; Hámori J
    Handchirurgie; 1980; 12(1-2):113-7. PubMed ID: 7195866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
    Kuhn MA; Payne WG; Kierney PC; Pu LL; Smith PD; Siegler K; Ko F; Wang X; Robson MC
    Int J Surg Investig; 2001; 2(6):443-56. PubMed ID: 12678125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigations regarding the pathogenesis of fibromatosis of the palmar fascia (Dupuytren's contracture) (author's transl)].
    Sonntag W; Paulini K
    Z Orthop Ihre Grenzgeb; 1976 Oct; 114(5):764-8. PubMed ID: 997730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine structural alterations of the palmar aponeurosis in Dupuytren's contracture. A combined scanning and transmission electronmicroscopic examination.
    Józsa L; Salamon A; Réffy A; Renner A; Demel S; Donhöffer A; Pintér T; Thöring J
    Zentralbl Allg Pathol; 1988; 134(1):15-25. PubMed ID: 3358315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal behavior of cultured fibroblasts from nodule and nonaffected aponeurosis of Dupuytren's disease.
    Azzarone B; Failly-Crepin C; Daya-Grosjean L; Chaponnier C; Gabbiani G
    J Cell Physiol; 1983 Dec; 117(3):353-61. PubMed ID: 6197420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupuytren's contracture. An electron microscopic, biochemical, and clinical correlative study.
    Gelberman RH; Amiel D; Rudolph RM; Vance RM
    J Bone Joint Surg Am; 1980 Apr; 62(3):425-32. PubMed ID: 7364813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular structure and biology of Dupuytren's disease.
    Tomasek JJ; Vaughan MB; Haaksma CJ
    Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.